Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS EQUITY (Narrative) (Details)

v3.22.2.2
STOCKHOLDERS EQUITY (Narrative) (Details)
1 Months Ended 3 Months Ended 6 Months Ended
Mar. 04, 2022
USD ($)
$ / shares
shares
May 12, 2021
USD ($)
$ / shares
shares
Aug. 29, 2022
USD ($)
$ / shares
shares
Jul. 29, 2022
USD ($)
shares
Jul. 25, 2022
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
shares
Jun. 30, 2022
USD ($)
shares
Sep. 30, 2021
USD ($)
shares
Jun. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
shares
Sep. 30, 2021
USD ($)
Jul. 29, 2022
$ / shares
Mar. 31, 2022
USD ($)
shares
Oct. 07, 2013
shares
Stockholders Equity Note [Line Items]                            
Preferred stock, shares authorized | shares           100,000,000       100,000,000     100,000,000 100,000,000
Aggregate cash payments   $ 3,000,000                        
Additional aggregate cash payments           $ 1,750,000       $ 1,750,000        
Aggregate cash payments for fiscal year 2023           250,000       250,000        
Aggregate cash payments for fiscal year 2024           250,000       250,000        
Stock compensation expense           806,758       1,613,515        
Stock compensation expense in quarter ended September 30, 2022                   806,758        
Stock compensation expense in quarter ended December 31, 2022                   806,758        
Stock compensation expense in quarter ended March 31, 2023                   806,758        
Total stock compensation expense for year ended March 31, 2023           3,227,030       3,227,030        
Stock compensation expense for years ended March 31, 2024           3,227,030       3,227,030        
Stock compensation expense years ended March 31, 2025           185,586       185,586        
Value of common stock shares issued upon conversion             $ 2,227,030              
Number of shares issued | shares     2,285,714                      
Convertible notes, aggregate principal amount           0       0     $ 2,223,633  
Exercise price of warrants | $ / shares     $ 0.46                      
Aggregate gross proceeds     $ 1,051,428             5,268,592 $ 4,995,250      
Stock Issued During Period, Value, New Issues             5,268,592 $ 4,995,250            
Amortization of debt discount                   1,598,855 $ 0      
Value of restricted shares granted           386,072 $ 222,017 $ 625,556 $ 651,648          
Series S Preferred Stock [Member]                            
Stockholders Equity Note [Line Items]                            
Value of common stock shares issued upon conversion   $ 6,681,090                        
Price per share | $ / shares   $ 1                        
Number of common stock shares issued upon conversion | shares   6,681,090                        
Vesting of stock recognized as prepaid expense   $ 2,227,030                        
Expenses related to stock           556,758       1,113,515        
Private Placement [Member]                            
Stockholders Equity Note [Line Items]                            
Convertible notes, aggregate principal amount $ 3,800,000                          
Notes maturity, description The Notes were to mature on September 4, 2022                          
Debt, accrue interest rate per annum 8.00%                          
Debt conversion price | $ / shares $ 0.8                          
Price per share | $ / shares $ 1.1                          
Subscription Agreement [Member]                            
Stockholders Equity Note [Line Items]                            
Number of shares issued | shares 475,000                          
Debt discount $ 345,455                          
Amortization of debt discount           121,619       294,346        
Debt Settlement Agreement [Member]                            
Stockholders Equity Note [Line Items]                            
Number of shares issued | shares         10,459,354                  
Convertible debt aggregate amount         $ 3,869,962                  
Convertible debt, principal amount         3,800,000                  
Accrued and unpaid interest         $ 69,962                  
Debt settlement price per share | $ / shares         $ 0.37                  
Debt conversion price | $ / shares         0.8                  
Price per share | $ / shares         $ 0.429                  
Non-cash inducement interest expense         $ 2,405,612                  
Warrant [Member]                            
Stockholders Equity Note [Line Items]                            
Beneficial conversion feature $ 1,524,750         $ 542,133       $ 1,304,508        
Number of shares issued | shares         10,459,354                  
Price per share | $ / shares         $ 1.1                  
Number of warrants issued to purchase of common stock | shares         10,459,354                  
Proceeds from issuance of warrants         $ 4,602,116                  
Common Stock [Member]                            
Stockholders Equity Note [Line Items]                            
Stock option and RSU-related compensation expense and common shares issued upon conversion of RSUs (in shares) | shares           500,000 221,665              
Value of common stock shares issued upon conversion             $ 2,227              
Number of common stock shares issued upon conversion | shares             2,227,030              
Stock Issued During Period, Shares, New Issues | shares             9,083,574 4,757,381            
Stock Issued During Period, Value, New Issues             $ 9,083 $ 4,757            
Value of restricted shares granted           $ 500 $ 222              
2020 Equity Incentive Plan [Member] | Frank Lazaran [Member]                            
Stockholders Equity Note [Line Items]                            
Stock option and RSU-related compensation expense and common shares issued upon conversion of RSUs (in shares) | shares       500,000                    
Price per share | $ / shares                       $ 0.428    
Value of restricted shares granted       $ 214,000                    
Maximum [Member] | Warrant [Member]                            
Stockholders Equity Note [Line Items]                            
Exercise price of warrants | $ / shares         $ 1.1                  
Minimum [Member] | Warrant [Member]                            
Stockholders Equity Note [Line Items]                            
Exercise price of warrants | $ / shares         $ 0.44